Johnp Schmid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Socket Mobile And 3 Other Stocks Under $3 Insiders Are Buying - Socket Mobile (NASDAQ:SCKT)

Socket Mobile And 3 Other Stocks Under $3 Insiders Are Buying - Socket Mobile (NASDAQ:SCKT)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Johnp schmidWilliam joseph mccarthyXeris biopharmaCharlie bassSocket mobile incXeris biopharma holdings incGraftech internationalDow jonesInvestments ltdGraftech international ltdComstock incOperating officer william joseph mccarthyComstock doesXeris biopharma holdingsXeris biopharma doesHow to earn

Design Therapeutics (NASDAQ:DSGN) Rating Increased to Overweight at Piper Sandler

Design Therapeutics (NASDAQ:DSGN) Rating Increased to Overweight at Piper Sandler
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesJohnp schmidPiper sandlerHermes incSecurities exchange commissionRoyal bankNisa investment advisorsSimplicity wealthDesign therapeutics incBleakley financial groupDesign therapeuticsGet free reportDirector johnExchange commissionFire capitalInvestment advisors

Design Therapeutics, Inc (NASDAQ:DSGN) Director Purchases $66,605 66 in Stock

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) Director John P. Schmid purchased 17,809 shares of Design Therapeutics stock in a transaction dated Monday, March 25th. The shares were bought at an average price of $3.74 per share, with a total value of $66,605.66. Following the completion of the acquisition, the director now directly owns […]

United statesJohnp schmidSecurities exchange commissionGroup plcNisa investment advisorsDesign therapeutics incTower research capitalRoyal bankDesign therapeutics company profileHermes incDesign therapeuticsGet free reportDirector johnExchange commissionFire capitalInvestment advisors

John P Schmid Acquires 9,156 Shares of Design Therapeutics, Inc (NASDAQ:DSGN) Stock

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) Director John P. Schmid acquired 9,156 shares of Design Therapeutics stock in a transaction on Friday, March 22nd. The stock was acquired at an average cost of $3.62 per share, for a total transaction of $33,144.72. Following the completion of the purchase, the director now owns 9,156 […]

United statesJohnp schmidDesign therapeutics company profileTower research capitalSecurities exchange commissionHermes incGroup plcRoyal bankNisa investment advisorsDesign therapeutics incDesign therapeuticsGet free reportDirector johnExchange commissionFire capitalInvestment advisors

Insider Buying: Design Therapeutics, Inc (NASDAQ:DSGN) Director Purchases 9,156 Shares of Stock

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) Director John P. Schmid bought 9,156 shares of the company’s stock in a transaction on Friday, March 22nd. The stock was purchased at an average cost of $3.62 per share, with a total value of $33,144.72. Following the completion of the transaction, the director now owns 9,156 […]

United statesJohnp schmidAmerica corpDesign therapeutics incManufacturers life insurance companyTower research capitalRoyal bankGroup plcAmerican international group incDesign therapeuticsGet free reportDirector johnGeneral group plcInternational groupResearch capitalDesign therapeutics daily